LC/MS, LC/MS/MS, LC/QQQ
IndustriesClinical Research
ManufacturerWaters
Significance of the Topic
Amino acids play central roles in metabolism, signaling, and disease processes. Rapid, accurate quantitation of a broad panel of proteinogenic and non‐proteinogenic amino acids is essential for biomedical research, clinical diagnostics, and metabolic profiling. The UPLC‐MS/MS approach described here addresses the need for high throughput, robust separation of isobaric species, and metrologically traceable calibration, facilitating confidence in quantitative results over a wide concentration range.
Study Objectives and Overview
This application note evaluates the performance of the Kairos Amino Acid Kit for the quantitative analysis of 45 amino acids in solution, urine, and plasma. Key goals include:
- Demonstrate baseline chromatographic separation of isobaric amino acids in under 10 minutes.
- Assess analytical figures of merit: precision, accuracy, linearity, sensitivity, and carryover.
- Illustrate the method’s applicability to real biological matrices.
Methodology and Instrumentation
Sample Preparation and Derivatization:
- 50 µL of sample mixed with internal standard and 0.1 M HCl; high‐concentration samples diluted as needed.
- Derivatization using AccQ•Tag Ultra “3X” chemistry with borate buffer: 1 min at room temperature, 10 min at 55 °C.
- Inject 2 µL of derivatized sample into the UPLC system.
Chromatography and Detection:
- Column: CORTECS UPLC C18 (1.6 µm, 2.1 × 150 mm), 55 °C.
- Mobile phase A: water + 0.1% formic acid; B: acetonitrile + 0.1% formic acid; flow rate 0.5 mL/min; 9 min gradient.
- MS/MS: Xevo TQ-S micro in positive ESI, MRM acquisition. Transitions optimized for each analyte and corresponding isotopically labeled internal standards.
Main Results and Discussion
Carryover:
- No significant detector carryover: blank signals ≤20% of the lowest calibrator.
Precision:
- Within-day CV ≤6.9%; between-day CV ≤13.9% (42 of 45 analytes).
Linearity:
- Calibration range up to 4000 µM for most analytes; r2 >0.99 with 1/x weighting.
- Back-calculated concentrations within ±15% except at LLOQ (±20%).
Sensitivity:
- LOQs ≤5 µM for the majority of amino acids; three analytes required higher LOQs (15–20 µM).
Accuracy:
- Panel samples: bias within ±20% for 42 analytes; three semi‐quantitative targets showed larger deviations.
- NIST SRM 2389a diluted to 400 µM: bias ≤±10% for matched analytes.
Biological Samples:
- Plasma: clear separation and quantification of isobaric species (α-, β-, γ-aminobutyric acids).
- Urine: quantitation of neurotransmitter precursors (histidine, alanine, phenylalanine) at physiological levels.
Instrumentation Used
- ACQUITY UPLC I-Class System with Column Heater
- CORTECS UPLC C18 Column (1.6 µm, 2.1 × 150 mm)
- Xevo TQ-S micro Mass Spectrometer
- AccQ•Tag Ultra “3X” Derivatization Kit
- MassLynx v4.1 with TargetLynx Application Manager
Benefits and Practical Applications
- High selectivity: baseline separation of critical isobaric amino acids.
- Fast throughput: complete 45‐analyte panel in under 10 minutes per injection.
- Robust calibration: traceable to NMIJ and NIST reference materials.
- Flexible platform: reversed-phase method without ion-pair reagents, allowing multimethod use on the same UPLC-MS/MS instrument.
- Stable derivatized samples reduce reprocessing and downtime.
Future Trends and Opportunities
Advances in amino acid profiling will benefit from:
- Extension to related metabolites (e.g., biogenic amines, modified amino acids) within the same workflow.
- Integration with high-resolution mass spectrometry for untargeted discovery and expanded panels.
- Automation of sample preparation and derivatization to support large clinical cohorts.
- Machine-learning algorithms for enhanced peak deconvolution and biomarker discovery.
- Application in single-cell and spatial metabolomics to link amino acid distributions with tissue heterogeneity.
Conclusion
The Kairos Amino Acid Kit coupled with UPLC-MS/MS offers a rapid, precise, and traceable solution for quantifying 45 amino acids in diverse matrices. Its robust performance and streamlined workflow make it well suited for biomedical research, clinical studies, and quality control applications where high throughput and analytical confidence are required.
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.